Research suggests that brain insulin resistance may be a key factor linking metabolic and neuropsychiatric comorbidities. Various studies are exploring the underlying mechanisms, including the roles of inflammation, metabolic dysfunction, and neurodegeneration, as well as potential biomarkers and therapeutic targets. The relationship between insulin resistance and conditions such as Alzheimer's disease is also being investigated, with multiple pathways and molecular mechanisms being examined.